Introduction: Melioidosis is caused by a Gramnegative bacteria known as Burkholderia pseudomallei. Clinical manifestation of the disease is unspecific, leading to wrong diagnosis and delayed in administration of appropriate antibiotics. Case Report: This case reported an atypical presentation of melioidosis in a 45-yearold Malay lady with underlying asthma and hypertension who presented with generalized abdominal pain for 14 days. A few days before admission she developed high grade fever and jaundice. She was initially treated as ascending cholangitis. The diagnosis was changed to disseminated melioidosis after computed tomography (CT) scan findings and isolation of B. pseudomallei from the blood culture. She was treated with antibiotics according to the melioidosis regime and responded well to the therapy. Conclusion: Acute cholangitis or cholecystitis is a rare presentation of melioidosis. High degree of suspicion is very crucial in a patient presented with any severe illness especially in an endemic area.
INTRODUCTION
Burkholderia pseudomallei is a highly pathogenic, Gram-negative saprophyte found in soil, groundwater, stagnant streams, rice paddies, and ponds [1] . Melioidosis is regularly reported from Southeast Asia and Northern Australia as well as from South Asia, China, and Brazil [2] . The most common risk factor identified was diabetes mellitus. Others include exposure to contaminated water or soil and occupation-related activities. Majority of patients presented with pneumonia which counted for 36-51% of total cases. Other less common sites of infection include blood stream, skin, bone, soft tissue, and liver [2] [3] [4] . Melioidosis presented with acute cholangitis is uncommon [5] . In this case report, we would like to share an atypical presentation of melioidosis. www.ijcasereportsandimages.com Tajudin et al. 2
CASE REPORT
A 45-year-old Malay lady with hypertension and asthma was a referred case from a district hospital for further management of acute obstructive cholangitis. She presented with generalized colicky abdominal pain for two weeks which later became persistent. It was associated with loss of appetite, nausea, and significant weight loss. Four days prior to admission she had high grade fever associated with chills and rigor. Otherwise denied symptoms such as tea colored urine or palecolored stool. At the Emergency Department, the patient was alert, conscious, jaundiced, afebrile with a blood pressure of 104/70 mmHg and a heart rate (HR) of 70 bpm. Lung findings were unremarkable. There was generalized epigastric and right hypochondriac tenderness upon abdominal examination. She was then admitted to a general surgical ward with a diagnosis of acute cholecystitis for further management.
However, just a few hours after admission, she deteriorated when her blood pressure dropped to 99/58 mmHg and HR of 140 bpm. At the same time, she developed respiratory distress with respiratory rate (RR) of 35-40 bpm and oxygen saturation (SpO 2 ) of 88% on high flow mask. Arterial blood gases (ABGs) were taken urgently and showed type I respiratory failure with metabolic acidosis. She was electively intubated and was transferred to the intensive care unit (ICU) for further management.
Other investigations showed mild renal impairment. Urea was 13.2 mmol/L, sodium 126 mmol/L, potassium 3.0 mmol/L, and creatinine 325 umol/L. Total white cell count (TWC) was 15.62 × 109/L with hemoglobin (Hb) of 9.3 g/dL and normal platelets count (196 × 109/L) on full blood count (FBC) analysis. There was markedly increased of alkaline phosphatase (ALP), 899 μ/L and aspartate transaminase (AST), 64 μ/L. She was diagnosed with diabetes mellitus type 2 during this admission when her HbA1c was high (13.3%). Chest and abdominal radiographs showed clear lung fields and normal bowel outline (bowel not dilated). Based on the clinical presentation and investigations results, she was treated empirically as septicemia secondary to ascending cholangitis with intravenous (IV) meropenem 1 g eight hourly and IV metronidazole 500 mg eight hourly.
Emergency ultrasonography of hepatobiliary system was done on the day of admission and showed hepatosplenomegaly as well as splenic lesion suggestive of an early abscess. Computed tomography scan of the abdomen was done two days later since the patient was not stable for the procedure to be done much earlier. Findings showed features of multifocal splenic and liver abscesses. Initial blood culture taken on the day of admission grew coagulase-negative Staphylococcus which was regarded as a contaminant. Repeat blood culture five days later grew two types of Gram-negative bacteria, lactose fermenter, and nonlactose fermenter organisms with metallic sheen colonies ( Figure 1 ). The bacteria were later confirmed as B. pseudomallei by automated VITEK2 identification system with 99% probability. She was then treated as disseminated melioidosis with high dose of IV ceftazidime, 2 g every eight hourly.
She was managed in the ICU for eight days, responded well to the melioidosis regime and was able to be transferred to a general ward to complete the IV antibiotics. Repeat ultrasonography of hepatobiliary system after two weeks of antibiotics therapy showed the presence of splenic abscess with resolved liver abscess. She then continued with IV ceftazidime for four weeks and discharged with oral trimethoprim-sulfamethoxazole to be completed for a total of five months.
DISCUSSION
Melioidosis can present with varies clinical manifestations, from acute to subacute or chronic diseases. These nonspecific presentations warrant high clinical suspicion, especially in endemic area since mortality rate is high if treatment is delayed. Studies from Australia and Thailand documented case fatality between 19% and 36% of their cases [6, 7] . Basically, B. pseudomallei is acquired through direct contact with the contaminated soil or water, inhalation, and ingestion. However, disease severity and duration of incubation period are associated with the size of infective inoculum [8] . Incubation period varies widely from case to case. A patient was reported to manifest the signs and symptoms of the disease after 62 years of exposure [9] .
The clinical patterns of cases reported from Malaysia were consistent with cases from other countries in South and Southeast Asia. They shared common primary presentations of pneumonia and soft tissue abscesses, while diabetes as a major risk factor [2] . Among the cases, pneumonia was the most common disease manifestation followed by soft tissue abscess. Mortality was three-fold higher in pneumonia compared to soft tissue abscess [2] . Internal abscesses were mainly noted in subcutaneous tissue followed by liver, spleen, and lung were the third most common sites [2] . During preparing of this manuscript, only two cases of melioidosis presented with cholangitis/cholecystitis had been reported [5, 10] . The first case is a Singaporean man presenting with fever, upper abdominal pain, and yellow eyes. The second case is a middle-aged man from Malaysia who presented with typical signs and symptoms of cholangitis; fever, jaundice, and right hypochondriac pain. This current third case was admitted with similar signs and symptoms of acute cholangitis. Acute abdomen is not a common presentation of melioidosis despite the fact that liver abscesses are among the common clinical manifestations [11] .
Diagnosis for this patient was confirmed five days after admission since clinical presentations were pointing toward another diagnosis. Furthermore, she has no background history of diabetes mellitus, a major risk factor and initial peripheral blood culture grew skin contaminant. Repeat blood cultures confirmed the diagnosis. Isolation of B. pseudomallei from clinical specimens is still considered to be the "gold standard" for the diagnosis. The culture method has high specificity (100%) but low in sensitivity (60%) [12] . It depends on the type of samples, culture media used, and method of identification. Burkholderia pseudomallei is a motile aerobic, nonspore forming Gram-negative bacillus. In the laboratory, it grows aerobically on most agar media and produces clearly visible colonies within 24-48 hours at 37 o C. Ashdown medium or modifications of it are commonly used and the organism demonstrates differing colonial morphology, with mostly smooth colonies initially and dry or wrinkled colonies on further incubation and can be identified reliably from its biochemical profile with kit-based systems [13] . Various serological test are available, however, these tests are of low sensitivities and specificities or lack of standardizations [14] .
Timely identification of B. pseudomallei as offending organism is very important because it is intrinsically resistant to many commonly used antibiotics. Appropriate antibiotic therapy for melioidosis will improve the prognosis in this highly fatal, disseminated, and bacteremic form of infection. All patients with B. pseudomallei infection should be treated with initial intensive therapy followed by eradication therapy. In the intensive therapy, IV ceftazidime, meropenem, or imipenem need to be given for at least two to four weeks duration [15] . The following eradication therapy is given for a duration of 12-20 weeks with oral trimethoprim-sulfamethoxazole or amoxicillin/clavulanate potassium for those who cannot tolerate trimethoprim-sulfamethoxazole [15] .
High suspicion for melioidosis is needed in a highrisk group of patient, such as the patient with diabetes mellitus, especially in an endemic region for melioidosis, in view of atypical presentations of the disease and also high mortality rate associated with it. The possibility of melioidosis as the infective etiology in patients presenting with severe ascending cholangitis or acute cholecystitis, particularly in susceptible patients and in endemic countries should be considered. Early recognition and prompt treatment with appropriate antibiotics would be lifesaving.
CONCLUSION
Acute cholangitis or cholecystitis is a rare presentation of melioidosis. High degree of suspicion is very crucial in a patient presented with any severe illness especially in an endemic area. Patients who are at risk for diabetes mellitus should be retested to confirm the current status especially when they presented with acute severe illness since early diagnosis and appropriate antibiotics management are the key factors for survival in melioidosis. *********
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